Value to the Fore: Flexible CRO Solutions Aim to Improve Pipeline Success
White Paper Apr 02, 2012
R&D outsourcing is widely used by pharmaceutical, biotechnology, agricultural and related industries. In order for this to continue, CRO's will need to make higher value contributions i collaborative drug discovery programs.
Trends indicate a return to value, as Contract Research Organizations (CROs) continue to grow their skill sets and ally with the global R&D industry to tap flexible solutions aimed at improving pipeline success. Bruce Molino, Ph.D., Senior Director of Medicinal Chemistry, and Christopher Conway, Senior Director of Business Development, AMRI, analyze the increasing demand for R&D outsourcing and examine how CROs are evolving to better meet industry needs.
Related White Papers
Evaluating Aggregation Behaviour of Liposome-protein Complexes using NTAWhite Paper
Malvern Instruments Limited
Rapid, high-resolution characterization of liposome-insulin receptor complexes in various buffer systems by Nanoparticle Tracking AnalysisREAD MORE
Ten Ways to…..Control Rheology by Changing Particle Properties (Size, Zeta Potential and Shape)White Paper
Malvern Instruments LimitedREAD MORE